APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetic Retinopathy Screening Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Diabetic Retinopathy Screening Software Market Outlook and Growth Opportunities 2026

2 May 2026191 pages

Choose your research edition.

Industry ResearchDiabetic Retinopathy Screening Software Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetic Retinopathy Screening Software Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Diabetic Retinopathy Screening Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetic Retinopathy Screening Software Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetic Retinopathy Screening Software Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Diabetic Retinopathy Screening Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Diabetic Retinopathy Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Diabetic Retinopathy Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diabetic Retinopathy Screening Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Diabetic Retinopathy Screening Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Diabetic Retinopathy Screening Software market include Retmarker, Retina Labs, Eyenuk, Inc., RetinaLyze, Intelligent Retinal Imaging Systems(IRIS), Retina AI, Optomed, RetinaRisk and InHealth Intelligence, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Diabetic Retinopathy Screening Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Diabetic Retinopathy Screening Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diabetic Retinopathy Screening Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Diabetic Retinopathy Screening Software market.

Diabetic Retinopathy Screening Software Segment by Company

Retmarker

Retina Labs

Eyenuk, Inc.

RetinaLyze

Intelligent Retinal Imaging Systems(IRIS)

Retina AI

Optomed

RetinaRisk

InHealth Intelligence

CSIRO

NEC Care

Diabetic Retinopathy Screening Software Segment by Type

Cloud Based

On-Premise

Diabetic Retinopathy Screening Software Segment by Application

Hospital Eye Diagnosis

Personal Screening

Medical Research

Diabetic Retinopathy Screening Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Diabetic Retinopathy Screening Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Diabetic Retinopathy Screening Software key companies, revenue, market share, and recent developments.

3. To split the Diabetic Retinopathy Screening Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Diabetic Retinopathy Screening Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Diabetic Retinopathy Screening Software significant trends, drivers, influence factors in global and regions.

6. To analyze Diabetic Retinopathy Screening Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Retinopathy Screening Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetic Retinopathy Screening Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Retinopathy Screening Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diabetic Retinopathy Screening Software industry.

Chapter 3: Detailed analysis of Diabetic Retinopathy Screening Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Diabetic Retinopathy Screening Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Diabetic Retinopathy Screening Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Diabetic Retinopathy Screening Software Industry Trends Table 2. Diabetic Retinopathy Screening Software Industry Drivers Table 3. Diabetic Retinopathy Screening Software Industry Opportunities and Challenges Table 4. Diabetic Retinopathy Screening Software Industry Restraints Table 5. Global Diabetic Retinopathy Screening Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Diabetic Retinopathy Screening Software Revenue Share by Company (2021-2026) Table 7. Global Diabetic Retinopathy Screening Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Diabetic Retinopathy Screening Software Key Company Manufacturing Base & Headquarters Table 9. Global Diabetic Retinopathy Screening Software Company, Product Type & Application Table 10. Global Diabetic Retinopathy Screening Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Diabetic Retinopathy Screening Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud Based Table 15. Significant Companies of On-Premise Table 16. Global Diabetic Retinopathy Screening Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Diabetic Retinopathy Screening Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Diabetic Retinopathy Screening Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Diabetic Retinopathy Screening Software Sales Value Share by Type (2021-2026) Table 20. Global Diabetic Retinopathy Screening Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Eye Diagnosis Table 22. Significant Companies of Personal Screening Table 23. Significant Companies of Medical Research Table 24. Global Diabetic Retinopathy Screening Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Diabetic Retinopathy Screening Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Diabetic Retinopathy Screening Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Diabetic Retinopathy Screening Software Sales Value Share by Application (2021-2026) Table 28. Global Diabetic Retinopathy Screening Software Sales Value Share by Application (2027-2032) Table 29. Global Diabetic Retinopathy Screening Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Diabetic Retinopathy Screening Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Diabetic Retinopathy Screening Software Sales Value Share by Region (2021-2026) Table 32. Global Diabetic Retinopathy Screening Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Diabetic Retinopathy Screening Software Sales Value Share by Region (2027-2032) Table 34. Global Diabetic Retinopathy Screening Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Diabetic Retinopathy Screening Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Diabetic Retinopathy Screening Software Sales Value Market Share by Country (2021-2026) Table 37. Global Diabetic Retinopathy Screening Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Diabetic Retinopathy Screening Software Sales Value Market Share by Country (2027-2032) Table 39. Retmarker Company Information Table 40. Retmarker Business Overview Table 41. Retmarker Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Retmarker Diabetic Retinopathy Screening Software Product Portfolio Table 43. Retmarker Recent Development Table 44. Retina Labs Company Information Table 45. Retina Labs Business Overview Table 46. Retina Labs Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Retina Labs Diabetic Retinopathy Screening Software Product Portfolio Table 48. Retina Labs Recent Development Table 49. Eyenuk, Inc. Company Information Table 50. Eyenuk, Inc. Business Overview Table 51. Eyenuk, Inc. Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Eyenuk, Inc. Diabetic Retinopathy Screening Software Product Portfolio Table 53. Eyenuk, Inc. Recent Development Table 54. RetinaLyze Company Information Table 55. RetinaLyze Business Overview Table 56. RetinaLyze Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. RetinaLyze Diabetic Retinopathy Screening Software Product Portfolio Table 58. RetinaLyze Recent Development Table 59. Intelligent Retinal Imaging Systems(IRIS) Company Information Table 60. Intelligent Retinal Imaging Systems(IRIS) Business Overview Table 61. Intelligent Retinal Imaging Systems(IRIS) Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Intelligent Retinal Imaging Systems(IRIS) Diabetic Retinopathy Screening Software Product Portfolio Table 63. Intelligent Retinal Imaging Systems(IRIS) Recent Development Table 64. Retina AI Company Information Table 65. Retina AI Business Overview Table 66. Retina AI Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Retina AI Diabetic Retinopathy Screening Software Product Portfolio Table 68. Retina AI Recent Development Table 69. Optomed Company Information Table 70. Optomed Business Overview Table 71. Optomed Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Optomed Diabetic Retinopathy Screening Software Product Portfolio Table 73. Optomed Recent Development Table 74. RetinaRisk Company Information Table 75. RetinaRisk Business Overview Table 76. RetinaRisk Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. RetinaRisk Diabetic Retinopathy Screening Software Product Portfolio Table 78. RetinaRisk Recent Development Table 79. InHealth Intelligence Company Information Table 80. InHealth Intelligence Business Overview Table 81. InHealth Intelligence Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. InHealth Intelligence Diabetic Retinopathy Screening Software Product Portfolio Table 83. InHealth Intelligence Recent Development Table 84. CSIRO Company Information Table 85. CSIRO Business Overview Table 86. CSIRO Diabetic Retinopathy Screening Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CSIRO Diabetic Retinopathy Screening Software Product Portfolio Table 88. CSIRO Recent Development Table 89. NEC Care Company Information Table 90. NEC Care Business Overview Table 91. NEC Care Diabetic Retinopathy Screening Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. NEC Care Diabetic Retinopathy Screening Software Product Portfolio Table 93. NEC Care Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Diabetic Retinopathy Screening Software Product Image Figure 2. Global Diabetic Retinopathy Screening Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diabetic Retinopathy Screening Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Diabetic Retinopathy Screening Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud Based Image Figure 8. On-Premise Image Figure 9. Global Diabetic Retinopathy Screening Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Diabetic Retinopathy Screening Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Diabetic Retinopathy Screening Software Sales Value Share by Type (2021-2032) Figure 12. Hospital Eye Diagnosis Image Figure 13. Personal Screening Image Figure 14. Medical Research Image Figure 15. Global Diabetic Retinopathy Screening Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Diabetic Retinopathy Screening Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Diabetic Retinopathy Screening Software Sales Value Share by Application (2021-2032) Figure 18. Global Diabetic Retinopathy Screening Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Diabetic Retinopathy Screening Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Diabetic Retinopathy Screening Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Diabetic Retinopathy Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Diabetic Retinopathy Screening Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Diabetic Retinopathy Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Diabetic Retinopathy Screening Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Diabetic Retinopathy Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Diabetic Retinopathy Screening Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Diabetic Retinopathy Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Diabetic Retinopathy Screening Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Diabetic Retinopathy Screening Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • On-Premise
Applications
  • Hospital Eye Diagnosis
  • Personal Screening
  • Medical Research
Companies covered
  • Retmarker
  • Retina Labs
  • Eyenuk, Inc.
  • RetinaLyze
  • Intelligent Retinal Imaging Systems(IRIS)
  • Retina AI
  • Optomed
  • RetinaRisk
  • InHealth Intelligence
  • CSIRO
  • NEC Care

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diabetic Retinopathy Screening Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diabetic Retinopathy Screening Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Diabetic Retinopathy Screening Software Market Dynamics
  1. 2.1 Diabetic Retinopathy Screening Software Industry Trends
  2. 2.2 Diabetic Retinopathy Screening Software Industry Drivers
  3. 2.3 Diabetic Retinopathy Screening Software Industry Opportunities and Challenges
  4. 2.4 Diabetic Retinopathy Screening Software Industry Restraints
3 Diabetic Retinopathy Screening Software Market by Company
  1. 3.1 Global Diabetic Retinopathy Screening Software Company Revenue Ranking in 2025
  2. 3.2 Global Diabetic Retinopathy Screening Software Revenue by Company (2021-2026)
  3. 3.3 Global Diabetic Retinopathy Screening Software Company Ranking (2024-2026)
  4. 3.4 Global Diabetic Retinopathy Screening Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Diabetic Retinopathy Screening Software Company Product Type and Application
  6. 3.6 Global Diabetic Retinopathy Screening Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Diabetic Retinopathy Screening Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Diabetic Retinopathy Screening Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Diabetic Retinopathy Screening Software Market by Type
  1. 4.1 Diabetic Retinopathy Screening Software Type Introduction
  2. 4.1.1 Cloud Based
  3. 4.1.2 On-Premise
  4. 4.2 Global Diabetic Retinopathy Screening Software Sales Value by Type
  5. 4.2.1 Global Diabetic Retinopathy Screening Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Diabetic Retinopathy Screening Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Diabetic Retinopathy Screening Software Sales Value Share by Type (2021-2032)
5 Diabetic Retinopathy Screening Software Market by Application
  1. 5.1 Diabetic Retinopathy Screening Software Application Introduction
  2. 5.1.1 Hospital Eye Diagnosis
  3. 5.1.2 Personal Screening
  4. 5.1.3 Medical Research
  5. 5.2 Global Diabetic Retinopathy Screening Software Sales Value by Application
  6. 5.2.1 Global Diabetic Retinopathy Screening Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diabetic Retinopathy Screening Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Diabetic Retinopathy Screening Software Sales Value Share by Application (2021-2032)
6 Diabetic Retinopathy Screening Software Regional Value Analysis
  1. 6.1 Global Diabetic Retinopathy Screening Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diabetic Retinopathy Screening Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Diabetic Retinopathy Screening Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Diabetic Retinopathy Screening Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diabetic Retinopathy Screening Software Sales Value (2021-2032)
  7. 6.3.2 North America Diabetic Retinopathy Screening Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Diabetic Retinopathy Screening Software Sales Value (2021-2032)
  10. 6.4.2 Europe Diabetic Retinopathy Screening Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Diabetic Retinopathy Screening Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Diabetic Retinopathy Screening Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Diabetic Retinopathy Screening Software Sales Value (2021-2032)
  16. 6.6.2 South America Diabetic Retinopathy Screening Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Diabetic Retinopathy Screening Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Diabetic Retinopathy Screening Software Sales Value Share by Country, 2025 VS 2032
7 Diabetic Retinopathy Screening Software Country-level Value Analysis
  1. 7.1 Global Diabetic Retinopathy Screening Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Diabetic Retinopathy Screening Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Diabetic Retinopathy Screening Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Diabetic Retinopathy Screening Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Diabetic Retinopathy Screening Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Diabetic Retinopathy Screening Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Diabetic Retinopathy Screening Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Retmarker
  2. 8.1.1 Retmarker Company Information
  3. 8.1.2 Retmarker Business Overview
  4. 8.1.3 Retmarker Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Retmarker Diabetic Retinopathy Screening Software Product Portfolio
  6. 8.1.5 Retmarker Recent Developments
  7. 8.2 Retina Labs
  8. 8.2.1 Retina Labs Company Information
  9. 8.2.2 Retina Labs Business Overview
  10. 8.2.3 Retina Labs Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Retina Labs Diabetic Retinopathy Screening Software Product Portfolio
  12. 8.2.5 Retina Labs Recent Developments
  13. 8.3 Eyenuk, Inc.
  14. 8.3.1 Eyenuk, Inc. Company Information
  15. 8.3.2 Eyenuk, Inc. Business Overview
  16. 8.3.3 Eyenuk, Inc. Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eyenuk, Inc. Diabetic Retinopathy Screening Software Product Portfolio
  18. 8.3.5 Eyenuk, Inc. Recent Developments
  19. 8.4 RetinaLyze
  20. 8.4.1 RetinaLyze Company Information
  21. 8.4.2 RetinaLyze Business Overview
  22. 8.4.3 RetinaLyze Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 RetinaLyze Diabetic Retinopathy Screening Software Product Portfolio
  24. 8.4.5 RetinaLyze Recent Developments
  25. 8.5 Intelligent Retinal Imaging Systems(IRIS)
  26. 8.5.1 Intelligent Retinal Imaging Systems(IRIS) Company Information
  27. 8.5.2 Intelligent Retinal Imaging Systems(IRIS) Business Overview
  28. 8.5.3 Intelligent Retinal Imaging Systems(IRIS) Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Intelligent Retinal Imaging Systems(IRIS) Diabetic Retinopathy Screening Software Product Portfolio
  30. 8.5.5 Intelligent Retinal Imaging Systems(IRIS) Recent Developments
  31. 8.6 Retina AI
  32. 8.6.1 Retina AI Company Information
  33. 8.6.2 Retina AI Business Overview
  34. 8.6.3 Retina AI Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Retina AI Diabetic Retinopathy Screening Software Product Portfolio
  36. 8.6.5 Retina AI Recent Developments
  37. 8.7 Optomed
  38. 8.7.1 Optomed Company Information
  39. 8.7.2 Optomed Business Overview
  40. 8.7.3 Optomed Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Optomed Diabetic Retinopathy Screening Software Product Portfolio
  42. 8.7.5 Optomed Recent Developments
  43. 8.8 RetinaRisk
  44. 8.8.1 RetinaRisk Company Information
  45. 8.8.2 RetinaRisk Business Overview
  46. 8.8.3 RetinaRisk Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RetinaRisk Diabetic Retinopathy Screening Software Product Portfolio
  48. 8.8.5 RetinaRisk Recent Developments
  49. 8.9 InHealth Intelligence
  50. 8.9.1 InHealth Intelligence Company Information
  51. 8.9.2 InHealth Intelligence Business Overview
  52. 8.9.3 InHealth Intelligence Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 InHealth Intelligence Diabetic Retinopathy Screening Software Product Portfolio
  54. 8.9.5 InHealth Intelligence Recent Developments
  55. 8.10 CSIRO
  56. 8.10.1 CSIRO Company Information
  57. 8.10.2 CSIRO Business Overview
  58. 8.10.3 CSIRO Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CSIRO Diabetic Retinopathy Screening Software Product Portfolio
  60. 8.10.5 CSIRO Recent Developments
  61. 8.11 NEC Care
  62. 8.11.1 NEC Care Company Information
  63. 8.11.2 NEC Care Business Overview
  64. 8.11.3 NEC Care Diabetic Retinopathy Screening Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NEC Care Diabetic Retinopathy Screening Software Product Portfolio
  66. 8.11.5 NEC Care Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst